Specifically, integrative bioinformatic analysis of genomics, transcriptomics, and proteomics data has aided in the discovery of prognostic markers, including the protein TIM3 and the gene HNRNPC [50,51], while few studies have utilized cell lines to explore the proteogenomic landscape of lung cancer, yielding significant findings awaiting validation in clinical samples [46,47,48]. This evidence concerns the gene HAVCR2 and lung carcinoma.